Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm(3): Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial

BACKGROUND: Low CD4+ recovery among HIV-positive individuals who achieve virologic suppression is common but has not been studied among individuals initiating treatment at CD4+ counts > 500 cells/mm(3). SETTING: United States, Africa, Asia, Europe & Israel, Australia, Latin America. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Boatman, Jeffrey A., Baker, Jason V., Emery, Sean, Furrer, Hansjakob, Mushatt, David M., Sedlacek, Dalibor, Lundgren, Jens D., Neaton, James D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456414/
https://ncbi.nlm.nih.gov/pubmed/30664075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados